Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Sep 16, 2025; 17(9): 108549
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.108549
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.108549
Table 1 Characteristics of the included studies on endoscopic ultrasound-guided portal pressure measurement
Ref. | Type of study | Number of studies included in manuscript | Country | Number of patients | Mean age (years) | Male/female | Comments/major findings |
Laleman et al[2] | Review | 20 | United States | N/A | N/A | N/A | EUS-guided portal pressure measurement viable alternative for HVPG |
Kolb et al[4] | Retrospective | 1 | United States | 385 | 57.23 | 188/197 (51.2) | First multicenter study evaluating EUS-guided portal pressure measurement |
Huang et al[5] | Prospective | 1 | United States | 28 | 63 | 18/10 (36) | EUS-portal pressure gradient measurement showing 100% success and no adverse events |
Laleman et al[6] | Review | 135 | United States | N/A | N/A | N/A | Suggests EUS-guided portal pressure gradient measurement is adequate alternative to hepatic vein catheterization |
Choi et al[7] | Retrospective | 1 | United States | 64 | 57.5 | 40/25 (37.5) | EUS-guided portal pressure gradient measurements have excellent correlation with histological hepatic fibrosis stage |
Hajifathalian et al[8] | Prospective | 1 | United States | 24 | 53 | 5/19 (79) | EUS-guided portosystemic pressure gradient combined with EUS-guided liver biopsy feasible, safe, accurate |
Choi et al[9] | Retrospective | 1 | United States | 83 | 59.4 | 51/32 (39) | Larger retrospective study showing EUS-guided portal pressure gradient measurement showing gradient was higher in patients with cirrhotic features |
Zhang et al[10] | Prospective | 1 | China | 12 | 63 | 9/3 (25) | EUS-guided portal pressure gradient measurement using 22-gauge fine-needle aspiration safe and accurate |
Gadour et al[11] | Systematic review and meta-analysis | 45 | 10 countries worldwide | N/A | N/A | N/A | Meta-analysis showing success rate of over 95% of EUS-guided portal pressure gradient measurement |
Vanderschueren et al[12] | Prospective | Recruiting | Pending | Recruiting | Pending | Pending | Active study to evaluating head-to-head comparison of HVPG and EUS-guided portal pressure measurement |
Table 2 Summarized version of the endoscopic ultrasound-guided portal pressure gradient measurement technique proposed by Laleman et al[2]
General technical steps in performing EUS-guided portal pressure gradient measurement |
Survey liver on EUS for potential focal lesions and blunting of liver edge, liver echotexture, gastric varices, and flow in portal and splenic veins |
EUS-shear wave elastography then used over left lobe of liver, spleen and then right lobe of liver from duodenum |
Best vessel chosen and pulse wave doppler used to confirm. Listen for continuous hum of the portal vein |
Typically, middle hepatic vein and left portal vein chosen |
Pressure gauge and 25-gauge needle device primed with saline or heparinized saline, manometer placed at phlebostatic axis (4th intercostal space, approximately at level of R atrium) |
Needle is then guided through parenchyma to vessel. Enter hepatic vein 2 cm from inferior vena cava convergence |
Flush needle with saline, then watch pressure gauge rise until reaches steady state for 1 minute |
Measurement repeated until 3 consecutive pressures are close together |
Average is the mean hepatic vein pressure |
Withdraw needle and apply doppler to ensure there is no hemorrhage |
Repeat for portal vein |
Table 3 Characteristics of the included studies on endoscopic ultrasound management of gastric, gastroesophageal and ectopic varices
Ref. | Type of study | Number of studies included in manuscript | Country | Number of patients | Mean age (years) | Male/female | Comments/major findings |
Dragomir et al[14] | Systematic review | 23 | N/A | N/A | N/A | N/A | EUS more reliable than conventional endoscopy for treatment of GV |
Yang et al[15] | Systematic review | 23 | China | N/A | N/A | N/A | Outlines and recommends different EUS-guided variceal management techniques |
Bahdi et al[16] | Prospective | 1 | United States | 1 | 41 | 1/0 (0) | Successful outcome in EUS-guided coiling and cyanoacrylate injection of ectopic duodenal varices |
Huang et al[5] | Prospective | 1 | United States | 28 | 63 | 28/10 (36) | Data regarding EUS diagnosis of varices |
Rudnick et al[17] | Systematic review | 32 | United States | N/A | N/A | N/A | Overall clinical success of EUS-guided GV therapies 100%, adverse event rated of 14% |
Sarin et al[18] | Prospective | 1 | India | 37 | 34.5, 36.1 | 37/10 (27.1) | EUS-guided cyanoacrylate is more effective for treatment of GV than sclerotherapy with alcohol |
O’Rourke et al[20] | Retrospective | 1 | United Kingdom | 20 | 59 | 20/9 (55) | EUS-guided GV obliteration with coil placement and thrombin is safe with acceptable medium-term efficacy |
Liu et al[19] | Prospective | 3 | China | 3 | 49.3 | 2/1 (33.3) | Three cases with successful outcomes of endoscopic sclerotherapy for jejunal ectopic varices |
Robles-Medranda et al[21] | Prospective | 1 | Equador | 60 | 61.8, 61.6 | 16/14 (46.7), 19/11 (36.7) | EUS-guided coil embolization with cyanoacrylate injection superior to coil treatment alone |
Table 4 Characteristics of the included studies on endoscopic ultrasound-assisted liver biopsy and treatment of liver tumors
Ref. | Type of study | Number of studies included in manuscript | Number of patients | Mean age (years) | Male/female | Comments/ major findings |
Rudnick et al[17] | Systematic review | 32 | N/A | N/A | N/A | EUS-guided liver biopsy is a good alternative to percutaneous or transjugular biopsy, allows for biopsies of both lobes |
Arruda do Espirito Santo et al[24] | Systematic review and meta-analysis | 4 | 258 | N/A | N/A | EUS-guided liver biopsy is safe and effective as percutaneous liver biopsy and has lower post-procedure pain |
McCarty et al[26] | Systematic review and meta-analysis | 5 | 656 | 51.62 | 298/368 (56.1) | EUS-guided liver biopsy is comparable to percutaneous and transjugular liver biopsy in specimens obtained and safety |
Table 5 Characteristics of the included studies on endoscopic ultrasound-guided caudate lobe ablation and sampling
Ref. | Type of study | Study setting | Country | Number of patients | Mean age (years) | Male/female | Comments/major findings |
De et al[27] | Prospective | Single center | India | 1 | 64 | 1/0 (0) | Complete ablation of small caudate lobe tumor using EUS-guided radiofrequency ablation |
Attili et al[28] | Prospective | Single center | Italy | 1 | 75 | 1/0 (0) | First documented case of EUS-guided caudate lobe tumor ablation |
Katrevula et al[29] | Prospective | Single center | India | 1 | 48 | 1/0 (0) | Successful ablation of caudate lobe tumor using EUS-guided radiofrequency ablation |
de Nucci et al[30] | Prospective | Single center | Italy | 10 | 78.6 | 5/5 (50) | Case series detailing EUS-guided caudate lobe tumor ablation of larger tumor |
Table 6 Characteristics of the included studies on other endoscopic ultrasound-guided procedures and indications
Ref. | Topic | Type of study | Number of studies included in manuscript | Country | Number of patients | Mean age (years) | Male/female | Comments/major findings |
Nimri et al[33] | EUS-LAMS | Retrospective | 1 | International | 43 | 58.4 | 22/21 (49) | EUS-LAMS deployment resulted in mainly mild adverse events |
Wilson et al[34] | EUS-guided cholecystojejunostomy | Prospective | 1 | United States | 1 | Unknown | 0/1 (100) | Suggests that EUS-guided placement of chlecystojejunostomy LAMS may offer effective management of acute cholecystitis |
Garg et al[35] | EUS-guided gallbladder drainage | Retrospective | 1 | United States, Spain | 170 | 66.5 (cirrhosis), 71.3 (no cirrhosis) | 29/18 (38.3) (cirrhosis), 68/55 (44.7) (no cirrhosis) | EUS-guided gallbladder drainage is effective in cirrhotic patients with a similar adverse event profile to non-cirrhotic patients |
Lisotti et al[36] | EUS-guided elastography | Systematic review | 14 | N/A | 52 | Unknown | Unknown | Reviews and highlights potential benefits of EUS-guided elastography |
AbiMansour et al[37] | EUS-guided shear wave elastography | Prospective | 1 | United States | 256 | 54.5 | 144/112 (43.8) | EUS-guided shear wave elastography shows reliability in detecting liver stiffness |
Wang et al[38] | EUS-guided shear wave elastography | Cross-sectional | 1 | United States | 62 | 49.2 | 20/42 (66.7) | EUS-guided shear wave elastography is superior to Fibrosis-4 Index and vibration-controlled transient elastography |
Diehl et al[39] | EUS-guided shear wave elastography | Prospective | 1 | United States | 52 | 48.4 | 20/32 (61.5) | EUS-guided shear wave elastography is less accurate in the left lobe and overall comparable to vibration-controlled transient elastography |
Fujii-Lau et al[40] | EUS-derived criteria for benign vs malignant hepatic masses | Retrospective | 1 | United States | 332 | 64 | 199/133 (40) | Introduces EUS scoring system to distinguish benign from malignant hepatic masses |
Nakai et al[41] | EUS-guided liver biopsy | Prospective | 1 | Japan | 17 | 64 | 12/5 (29) | EUS-guided liver biopsy is safe and feasible |
Laleman et al[42] | EUS-guided shunt obliteration and EUS-guided intrahepatic portosystemic shunt | Review | 45 | Unknown | N/A | N/A | N/A | Details future potential for intrahepatic portosystemic shunt |
Rathi et al[43] | EUS-guided shunt obliteration | Prospective | 1 | India | 7 | 54.3 | Unknown | Shows technical success in EUS-guided transgastric shunt obliteration |
Buscaglia et al[44] | EUS-guided intrahepatic portosystemic shunt | Prospective | 1 | United States | Pigs | N/A | N/A | EUS-guided intrahepatic portosystemic shunt is feasible and an alternative to transjugular intrahepatic portosystemic shunt |
Table 7 Characteristics of the included studies on safety profiles of endoscopic ultrasound procedures in cirrhosis
Ref. | Topic | Type of study | Number of studies included in manuscript | Country | Number of patients | Mean age (years) | Male/female | Comments/major findings |
Facciorusso et al[45] | Safety of EUS-guided fine needle aspiration | Retrospective | 1 | Italy | 190 | 64 | 114/76 (40) | The rate of adverse events of EUS-guided fine needle aspiration is higher in cirrhotic patients |
Garg et al[35] | Safety of EUS-guided gallbladder drainage | Retrospective | 1 | United States, Spain | 170 | 66.5 (cirrhosis), 71.3 (no cirrhosis) | 29/18 (38.3) (cirrhosis), 68/55 (44.7) (no cirrhosis) | Similar adverse events were seen in cirrhotic patients vs non-cirrhotic patients in EUS-guided gallbladder drainage |
Gadour et al[11] | Safety of EUS-guided liver abscess drainage and GV management | Systematic review and meta-analysis | 45 | 10 countries worldwide | N/A | N/A | N/A | EUS-guided GV management and liver biopsy have low complication rates |
Choi et al[9] | Safety of EUS-guided portal pressure gradient measurement and liver biopsy | Retrospective | 1 | United States | 83 | 59.4 | 51/32 (39) | Demonstrated no adverse events in EUS-guided portal pressure gradient measurement and liver biopsy |
- Citation: Castleberry DT, Mann R, Tharian B, Thandassery RB. Endoscopic ultrasound in the management of complications related to cirrhosis- recent evidence. World J Gastrointest Endosc 2025; 17(9): 108549
- URL: https://www.wjgnet.com/1948-5190/full/v17/i9/108549.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i9.108549